About Senores Pharmaceuticals:
The company is a global, research-driven pharmaceutical firm focused on developing and manufacturing generic pharmaceutical products in the B2B segment, primarily for regulated markets like the US, Canada, and the UK. It specializes in niche, complex products and has received approvals for 19 ANDAs as of March 31, 2024. Additionally, the company develops and manufactures generic products for emerging markets across 43 countries. It also operates a Critical Care Injectables business in India and manufactures APIs for the domestic market and SAARC countries.
About the Industry in which Senores Pharmaceuticals operates:
According to the F&S Report, the US pharmaceutical market grew from USD 589.0 billion in CY 2021 to USD 711.0 billion in CY 2023. The US CDMO market expanded from USD 36.3 billion in CY 2021 to USD 44.7 billion in CY 2023. The emerging pharmaceutical market increased from USD 354.3 billion in CY 2021 to USD 376.3 billion in CY 2023. The Indian hospital channel market grew from USD 3.9-4.7 billion in CY 2021 to USD 4.7-5.7 billion in CY 2023, while the India API market rose from USD 11.5 billion to USD 13.1 billion during the same period.
Important Information and Timelines of the IPO of Senores Pharmaceuticals:
Open Date 20 December 2024
Close Date 24 December 2024
Total Issue Size – Number of Shares 14887723
Minimum Bid Price 372
Maximum Bid Price 391
Lot Size 38
Basis of Allotment 26 December 2024
Initiation of Refunds and Credit of Shares to Demat 27 December 2024
Listing Date 30 December 2024
Listing Exchange(s) NSE and BSE
Minimum and Maximum Lot Sizes for the IPO of Senores Pharmaceuticals:
Category Lots Shares Amount (in ₹)
Retail – Minimum 1 38 14858
Retail – Maximum 13 494 193154
sHNI – Minimum 14 532 208012
sHNI – Maximum 67 2546 995486
bHNI – Minimum 68 2584 1010344
Objective of the IPO of Senores Pharmaceuticals:
- Investment in the company’s subsidiary, Havix, to fund capital expenditure for setting up a sterile injection manufacturing facility at the Atlanta facility.
- Repayment or prepayment, in full or in part, of certain borrowings availed by the company.
- Investment in Havix for the repayment or prepayment, in full or in part, of borrowings availed by the subsidiary.
- Funding the working capital requirements of the company.
- Investment in subsidiaries, SPI and Ratnatris, to support their working capital needs.
- Funding inorganic growth through acquisitions, strategic initiatives, and general corporate purposes.
Financials of Senores Pharmaceuticals:
| Particulars | Six months ended September 30, 2024 | March 31, 2024 | March 31, 2023 | March 31, 2022 |
|---|---|---|---|---|
| Equity Share Capital | 332.66 | 305.05 | 98.15 | 87.42 |
| Net Worth | 2,915.01 | 2,042.68 | 454.99 | 365.90 |
| Total Income | 1,833.53 | 2,173.42 | 390.21 | 146.31 |
| Restated Profit/(Loss) for the Year/Period | 239.43 | 327.08 | 84.33 | 9.91 |
| Earnings per Share (in ₹/share) - Basic | 7.20* | 13.67 | 8.87 | 1.81 |
| Earnings per Share (in ₹/share) - Diluted | 7.20* | 12.21 | 6.65 | 1.81 |
| Net Asset Value per Share (in ₹/share) | 87.63 | 66.96 | 46.36 | 41.86 |
| Total Borrowings | 2,420.33 | 2,483.84 | 607.63 | 142.07 |
For more details on the IPO, refer to the DRHP here.
Did you know that you can now Pre-Apply for an IPO on Dhan? You can place your IPO Bid on Dhan and the order will be pushed to the Exchange as soon as the Bidding starts for Senores Pharmaceuticals. You will receive a UPI mandate after 10:00 AM on 20 December 2024.
###1. How to apply for the IPO of Senores Pharmaceuticals on Dhan?
You can apply for the IPO of Senores Pharmaceuticals from either Dhan Mobile App or Web
On Dhan Mobile App you can find the IPO under the Money Section > IPO Tab
On Dhan Web you can find the IPO under Markets Tab > IPOs
###2. In case of successful allotment, when the IPO shares of Senores Pharmaceuticals be visible on Dhan?
The CDSL will intimate you regarding the credit of shares into your Demat account by 27 December 2024. However, you will be able to see the shares of Senores Pharmaceuticals on Dhan before the market starts on the listing date which is 30 December 2024.